Takeda Pharmaceutical (TAK) Goodwill & Intangibles (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Goodwill & Intangibles of $58.2 billion for Q2 2026, down 3.39% year-over-year from $60.3 billion in Q2 2025, and down 1.08% quarter-over-quarter from $58.8 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $58.2 billion for Q2 2026.
- In Q2 2026, Goodwill & Intangibles fell 3.39% year-over-year to $58.2 billion; the TTM figure through Jun 2026 stood at $58.2 billion (down 3.39% YoY), while the FY2026 annual figure was $61.3 billion, up 4.27% from the prior year.
- Goodwill & Intangibles for Q2 2026 stood at $58.2 billion, down from $58.8 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $70.8 billion in Q1 2022, with the low at $58.2 billion in Q2 2026.
- The 5-year median for Goodwill & Intangibles is $62.3 billion (2023), against an average of $63.5 billion.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles decreased 14.52% in 2022, then gained 4.07% in 2023.
- Takeda Pharmaceutical's Goodwill & Intangibles stood at $59.9 billion in 2022, then gained by 4.07% to $62.3 billion in 2023, then rose by 0.04% to $62.3 billion in 2024, then retreated by 3.35% to $60.2 billion in 2025, then declined by 3.35% to $58.2 billion in 2026.
- Business Quant data shows TAK's Goodwill & Intangibles at $58.2 billion in Q2 2026, $58.8 billion in Q1 2026, and $60.2 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.21 Bn |
| Mar 31, 2026 | 58.85 Bn |
| Dec 31, 2025 | 60.23 Bn |
| Sep 30, 2025 | 59.25 Bn |
| Jun 30, 2025 | 60.25 Bn |
| Mar 31, 2025 | 58.70 Bn |
| Dec 31, 2024 | 62.32 Bn |
| Sep 30, 2024 | 59.87 Bn |
| Jun 30, 2024 | 64.88 Bn |
| Mar 31, 2024 | 65.35 Bn |
| Dec 31, 2023 | 62.30 Bn |
| Sep 30, 2023 | 67.19 Bn |
| Jun 30, 2023 | 70.75 Bn |
| Mar 31, 2023 | 68.50 Bn |
| Dec 31, 2022 | 59.86 Bn |
| Sep 30, 2022 | 66.48 Bn |
| Jun 30, 2022 | 69.27 Bn |
| Mar 31, 2022 | 70.79 Bn |
| Dec 31, 2021 | 70.02 Bn |
| Sep 30, 2021 | 71.42 Bn |